Active Ingredient: SAXAGLIPTIN HYDROCHLORIDE
Proprietary Name: SAXAGLIPTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A205972
Product Number: 001
Approval Date: Jul 31, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information